Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients

BACKGROUND. Type 2 diabetes mellitus (T2DM) is prevalent in patients undergoing heart transplant, and in those without preexisting T2DM, posttransplant diabetes mellitus may develop. Both T2DM and posttransplant diabetes mellitus have been associated with increased morbidity and mortality following...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transplant Direct
Hlavní autoři: Cehic, Matthew G., Muir, Christopher A., Greenfield, Jerry R., Hayward, Christopher, Jabbour, Andrew, Keogh, Anne, Kotlyar, Eugene, Muthiah, Kavitha, Macdonald, Peter S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2019
Témata:
Heart Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511439/
https://ncbi.nlm.nih.gov/pubmed/31165085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000885
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky